Stay updated on ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Sign up to get notified when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.

Latest updates to the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe location entry for the Italian site was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded hepatocellular carcinoma to the study conditions and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision history updated: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check51 days agoChange DetectedGastric cancer was added to the conditions, and the Genetic and Rare Diseases Information Center resources link was included; the page revision was updated to v3.4.2, and the old v3.4.1 revision as well as the government funding lapse notice were removed.SummaryDifference0.5%

- Check58 days agoChange DetectedA new site-wide notice about a lapse in government funding was added, including guidance to check cc.nih.gov and opm.gov for status updates. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check65 days agoChange DetectedThe page adds a glossary option, updates QC-related labeling, and includes a new revision version note (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) while removing similar lowercase-labeled items. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 Combo in Advanced GI Cancers Clinical Trial page.